Brought to you by 
Cellomics, J&J to develop drug discovery tools
13 Jul 1999
Executive Summary
Cellomics (formerly BioDx; cell-based screening) allied with J&J's RW Johnson Pharmaceutical Research Institute to develop new high content drug discovery tools using Cellomics' ArrayScan system.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com